Categories: News

OCuSOFT Inc. Issues Clarification on Retaine® MGD™ Availability

ROSENBERG, Texas, Sept. 30, 2025 /PRNewswire/ — OCuSOFT Inc., a privately-held eye and skin care pharma company recognized as developing the first eyelid hygiene cleansing agent, today announced an important clarification regarding the availability of its preservative-free artificial tear, Retaine® MGD.

Recently, misleading information has circulated suggesting that OCuSOFT® Retaine® MGD™ is no longer available. This information is inaccurate. In 2024, OCuSOFT Inc. made a corporate decision to discontinue its previous formulation of Retaine® MGD™ and replace it with an advanced formulation branded as Retaine® MGD™ Advanced™.

“Unfortunately, intentionally deceptive methods have been used in certain marketing and sales avenues to imply that Retaine® MGD™ has been discontinued entirely,” said Troy Smith, Senior Vice President Group Development North America at OCuSOFT Inc. “This is simply not the case. Our updated formulation, Retaine® MGD™ Advanced™, is widely available and offers significant benefits through the use of electrostatic nano technology.”

Retaine® MGD™ Advanced™ can be obtained through a wide range of channels including optometric and ophthalmic offices nationwide, both for sale and as samples. Retaine® MGD™ Advanced™ is also available through most retail pharmacies and online retailers, including Amazon. In addition, OCuSOFT Inc. offers special discount pricing to eye care professionals, encouraging direct purchases for in-office distribution to patients.

OCuSOFT Inc. remains committed to supporting eye care professionals and their patients with innovative, effective products designed to improve ocular health. “We value the trust and support of the eye care community and are proud to continue offering products like Retaine® MGD™ Advanced™ that meet the highest standards of quality and efficacy,” added Smith.

For more information about Retaine® MGD™ Advanced™ or OCuSOFT®‘s full range of eye care solutions, please contact OCuSOFT Inc. directly at www.ocusoft.com or by calling (800) 233-5469

About OCuSOFT Inc.
OCuSOFT Inc. is a privately-held company widely known for its OCuSOFT® Lid Scrub® (OLS) family of eyelid hygiene products. OCuSOFT Inc. offers a complete line of eye care products including not only the OLS hygiene group but also Retaine® MGD™ Advanced™ preservative-free artificial tears, Retaine® CMC®, HypoChlor® Spray, and many others. OCuSOFT Inc. established the Southwest Research & Technology Center which houses numerous eye care related companies including Primera Research Pharma, LLC.  Through a licensing agreement, Primera Compounding, LLC developed the first medicated eyelid cleanser containing both OLS coupled with azithromycin, now available through prescription as Biune™ Eyelid Spray. 

For more information on OCuSOFT Inc.:
Contact: George Haines, Executive Vice President
Phone: (800) 233-5469
Email: ghaines@ocusoft.com

For more information on Primera Compounding, LLC:
Contact: Patty Heinz, President of Corporate Administration & Compliance
Phone: (800) 233-5469
Email: pheinz@primerarx.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/ocusoft-inc-issues-clarification-on-retaine-mgd-availability-302570499.html

SOURCE OCuSOFT Inc.

Staff

Recent Posts

The UA Sprinkler Fitters Local 669 JATC – Notice of Privacy Incident

Landover, Maryland, February 6, 2026- The UA Sprinkler Fitters Local 669 Joint Apprenticeship and Training…

13 minutes ago

Abbott Laboratories Announces Measurable Results From LATAM Diagnostic Market Development and Training Initiative Led by Claudia Marcela Riaño Caro

Regional program delivers double-digit sales growth, improved service performance, and expanded diagnostic access across Latin…

6 hours ago

GEARWRENCH Continues to Redefine Automotive Diagnostics with Powerful New Tools

Four new products available now to put full diagnostics in the palm of technician's handsSPARKS,…

6 hours ago

Tampa General’s Innovation Week Returns with New Programming to Showcase Breakthroughs in Patient Care and Technology

Global leaders, entrepreneurs and innovators will converge across the Tampa Medical & Research District and…

6 hours ago

New England Biolabs ® Proudly Partners with Automation Providers to Support NGS Library Prep Automation Globally

IPSWICH, Mass., Feb. 6, 2026 /PRNewswire/ -- New England Biolabs (NEB ®) will present several…

6 hours ago

Healthcare Triangle, Inc. Announces 1-for-60 Reverse Stock Split as Part of Nasdaq Compliance Plan

PLEASANTON, Calif., Feb. 6, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"),…

12 hours ago